Co-Authors
This is a "connection" page, showing publications co-authored by JIANJUN GAO and DAVID SANGHYUN HONG.
Connection Strength
0.097
-
Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials. Clin Genitourin Cancer. 2022 02; 20(1):e16-e24.
Score: 0.049
-
Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes. Mol Cancer Res. 2021 03; 19(3):395-402.
Score: 0.047